Elgan Pharma Announces Positive Results from its Phase III Study of ELGN-GI in Preterm Infants for Treatment of Intestinal Malabsorption March 2, 2022
Efficacy and Safety of Enteral Recombinant Human Insulin in Preterm Infants - A Randomized Clinical Trial February 28, 2022
Efficacy and Safety of Enteral Recombinant Human Insulin for Reduction of Time-to-Full Enteral Feeding in Preterm Infants: A Randomized, Double-blind, Placebo-Controlled Trial September 23, 2021
Oral Insulin Supplementation in Paediatric Short Bowel Disease: A Pilot Observational Study July 11, 2009
Oral Insulin Enhances Intestinal Regrowth Following Massive Small Bowel Resection in Rat December 10, 2005
Effect of Enteral Administration of Insulin on Intestinal Development and Feeding Tolerance in Preterm Infants: A Pilot Study March 3, 2002
Oral Insulin Increases Small Intestinal Mass and Disaccharidase Activity in the Newborn Miniature Pig August 28, 1990
